UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Therapy with rituximab for autoimmune pemphigus: Results from a single-center observational study on 42 cases with long-term follow-up

Journal of the American Academy of Dermatology, 2012-10, Vol.67 (4), p.617-622

2012

Volltextzugriff (PDF)

Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology

Journal of the American Academy of Dermatology, 2020-11, Vol.83 (5), p.1315-1322

2020

Volltextzugriff (PDF)

A population-based study of the association between bullous pemphigoid and neurologic disorders

Journal of the American Academy of Dermatology, 2014-12, Vol.71 (6), p.1191-1197

2014

Volltextzugriff (PDF)

Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study

BMJ, 2008-07, Vol.337 (jul09 1), p.a180-a180

International edition, 2008

Volltextzugriff (PDF)

Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome

Journal of allergy and clinical immunology, 2012-06, Vol.129 (6), p.1562-1569.e5

2012

Volltextzugriff (PDF)

Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: A series of 145 cases

Journal of the American Academy of Dermatology, 2015-07, Vol.73 (1), p.50-55

2015

Volltextzugriff (PDF)

Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome

Journal of allergy and clinical immunology, 2011-12, Vol.128 (6), p.1266-1276.e11

2011

Volltextzugriff (PDF)

Epidermolysis bullosa and the risk of life-threatening cancers: The National EB Registry experience, 1986-2006

Journal of the American Academy of Dermatology, 2009-02, Vol.60 (2), p.203-211

2009

Volltextzugriff (PDF)

Rituximab for treatment-refractory pemphigus and pemphigoid: A case series of 17 patients

Journal of the American Academy of Dermatology, 2011-09, Vol.65 (3), p.552-558

2011

Volltextzugriff (PDF)

Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study

Journal of the American Academy of Dermatology, 2008, Vol.58 (1), p.33-40

2008

Volltextzugriff (PDF)

Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel

Journal of the American Academy of Dermatology, 2008, Vol.58 (1), p.25-32

2008

Volltextzugriff (PDF)

Nonbullous pemphigoid: Insights in clinical and diagnostic findings, treatment responses, and prognosis

Journal of the American Academy of Dermatology, 2019-08, Vol.81 (2), p.355-363

2019

Volltextzugriff (PDF)

Treatment of Pemphigus Vulgaris with Rituximab and Intravenous Immune Globulin

The New England journal of medicine, 2006-10, Vol.355 (17), p.1772-1779

2006

Volltextzugriff (PDF)

Subcorneal pustular dermatosis‐type IgA pemphigus associated with multiple myeloma: A case report and literature review

Journal of dermatology, 2023-02, Vol.50 (2), p.234-238

2023

Volltextzugriff (PDF)

A review of causes of Stevens–Johnson syndrome and toxic epidermal necrolysis in children

Archives of disease in childhood, 2013-12, Vol.98 (12), p.998-1003

2013

Volltextzugriff (PDF)

Mortality of bullous pemphigoid: An evaluation of 223 patients and comparison with the mortality in the general population in the United States

Journal of the American Academy of Dermatology, 2008-10, Vol.59 (4), p.582-588

2008

Volltextzugriff (PDF)

A prospective study comparing patients with early and late relapsing pemphigus treated with rituximab

Journal of the American Academy of Dermatology, 2018-07, Vol.79 (1), p.97-103

Saleh, Marwah Adly

2018

Volltextzugriff (PDF)

Recurrent erythema multiforme: Clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007

Journal of the American Academy of Dermatology, 2010-01, Vol.62 (1), p.45-53

2010

Volltextzugriff (PDF)

Treatment and mortality rate of bullous pemphigoid in China: a hospital-based study

EJD. European journal of dermatology, 2013, Vol.23 (1), p.94-98

2013

Volltextzugriff (PDF)

Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris

Journal of the American Academy of Dermatology, 2007-10, Vol.57 (4), p.622-628

2007

Volltextzugriff (PDF)

Toxic epidermal necrolysis: Five years of treatment experience from a burn unit

Journal of the American Academy of Dermatology, 2012-10, Vol.67 (4), p.630-635

2012

Volltextzugriff (PDF)

Venous thromboembolism in patients with pemphigus: A cohort study

Journal of the American Academy of Dermatology, 2017-08, Vol.77 (2), p.256-260

2017

Volltextzugriff (PDF)

Erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis associated with lupus erythematosus

Journal of the American Academy of Dermatology, 2012-09, Vol.67 (3), p.417-421

2012

Volltextzugriff (PDF)

Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect?

Clinical and experimental rheumatology, 2012-09, Vol.30 (5), p.700

2012

Volltextzugriff (PDF)

Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: A retrospective study of 47 patients

Journal of the American Academy of Dermatology, 2013-03, Vol.68 (3), p.404-411

2013

Volltextzugriff (PDF)

1 – 25 von 559

Suche als RSS-Feed

Aktive Filter

KollektionSingle Journals

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(421)
Mit Volltextzugriff
(316)

Publikationsform

Artikel
(559)

Sprache

Englisch
(559)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Therapy with rituximab for autoimmune pemphigus: Results from a single-center observational study on 42 cases with long-term follow-up

Multicenter prospective study on multivariant diagnostics of autoimmune bullous dermatoses using the BIOCHIP technology

A population-based study of the association between bullous pemphigoid and neurologic disorders

Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study

Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome

Coexistence of autoimmune bullous diseases (AIBDs) and psoriasis: A series of 145 cases

Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome

Epidermolysis bullosa and the risk of life-threatening cancers: The National EB Registry experience, 1986-2006

Rituximab for treatment-refractory pemphigus and pemphigoid: A case series of 17 patients

Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: A retrospective study on patients included in the prospective EuroSCAR Study

Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel

Nonbullous pemphigoid: Insights in clinical and diagnostic findings, treatment responses, and prognosis

Treatment of Pemphigus Vulgaris with Rituximab and Intravenous Immune Globulin

Subcorneal pustular dermatosis‐type IgA pemphigus associated with multiple myeloma: A case report and literature review

A review of causes of Stevens–Johnson syndrome and toxic epidermal necrolysis in children

Mortality of bullous pemphigoid: An evaluation of 223 patients and comparison with the mortality in the general population in the United States

A prospective study comparing patients with early and late relapsing pemphigus treated with rituximab

Recurrent erythema multiforme: Clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007

Treatment and mortality rate of bullous pemphigoid in China: a hospital-based study

Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris

Toxic epidermal necrolysis: Five years of treatment experience from a burn unit

Venous thromboembolism in patients with pemphigus: A cohort study

Erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis associated with lupus erythematosus

Anti-tumour necrosis factor alpha therapy and increased risk of de novo psoriasis: is it really a paradoxical side effect?

Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: A retrospective study of 47 patients

Aktive Filter

Suchergebnisse filtern